GlassScriptPhysician profile
Allison L Scott
NPI 1205239282
$8,308.90
in general payments reported to CMS, 2019-2025
33 companies · $2,846 in 2025
The $2,846 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $231 · 2023: $1,468 · 2024: $3,568 · 2025: $2,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,814 · Travel and Lodging: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,814.35 |
| Travel and Lodging | $1,067.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,077.37 | 2023-2025 | Atriclip Laa Exclusion System |
| Aop Health US, LLC | $1,108.72 | 2025 | Rapiblyk |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $953.49 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $802.66 | 2023-2025 | Farxiga, Brilinta, Lokelma |
| Abbott Laboratories | $694.54 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $399.31 | 2022-2025 | Camzyos, Eliquis |
| Pfizer INC. | $390.75 | 2023-2025 | |
| Inari Medical, INC. | $215.89 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $198.87 | 2023-2024 | Rybelsus, Ozempic |
| Impulse Dynamics (USA) INC. | $168.85 | 2024-2025 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.61 | 2022-2025 | Jardiance |
| Philips North America LLC | $151.12 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Boston Scientific Corporation | $147.89 | 2022 | |
| Janssen Pharmaceuticals, INC | $144.36 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $129.42 | 2023-2025 | Verquvo |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $103.78 | 2023-2024 | Repatha |
| Abiomed | $60.78 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $57.60 | 2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Novartis Pharmaceuticals Corporation | $55.83 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $33.09 | 2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $32.54 | 2023-2025 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $28.15 | 2024 | Uptravi, Opsumit |
| Kiniksa Pharmaceuticals International, Plc | $24.71 | 2024 | Arcalyst |
| Medtronic, INC. | $24.31 | 2025 | Mycarelink |
| Bayer Healthcare Pharmaceuticals INC. | $22.95 | 2023 | |
| Lilly USA, LLC | $18.00 | 2025 | Zepbound |
| Regeneron Healthcare Solutions, INC. | $16.94 | 2023 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $14.89 | 2024 | |
| Cvrx, INC. | $14.48 | 2025 | Barostim Neo System |
| Davol INC. | $14.28 | 2025 | Arista |
| Cardiva Medical, INC. | $13.93 | 2023 | Cardiva Vascade 6/7f Vcs |
| Lexicon Pharmaceuticals, INC. | $13.91 | 2023 | Inpefa |
| Heartflow, INC. | $13.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.